News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,833 Results
Type
Article (39397)
Company Profile (306)
Press Release (648130)
Section
Business (204773)
Career Advice (2001)
Deals (35473)
Drug Delivery (87)
Drug Development (80978)
Employer Resources (168)
FDA (16116)
Job Trends (14857)
News (345782)
Policy (32544)
Tag
Academia (2548)
Alliances (49402)
Alzheimer's disease (1231)
Approvals (16042)
Artificial intelligence (125)
Bankruptcy (354)
Best Places to Work (11550)
Biotechnology (217)
Breast cancer (117)
Cancer (1033)
Cardiovascular disease (86)
Career advice (1670)
Cell therapy (222)
Clinical research (64244)
Collaboration (367)
Compensation (188)
COVID-19 (2544)
C-suite (87)
Data (1042)
Diabetes (151)
Diagnostics (6152)
Earnings (84923)
Employer resources (146)
Events (109844)
Executive appointments (279)
FDA (16623)
Funding (332)
Gene therapy (170)
GLP-1 (576)
Government (4336)
Healthcare (18683)
Infectious disease (2626)
Inflammatory bowel disease (108)
Interviews (308)
IPO (16317)
Job creations (3658)
Job search strategy (1428)
Layoffs (417)
Legal (7886)
Lung cancer (165)
Manufacturing (171)
Medical device (13180)
Medtech (13185)
Mergers & acquisitions (19212)
Metabolic disorders (392)
Neuroscience (1489)
NextGen Class of 2024 (6534)
Non-profit (4475)
Northern California (1416)
Obesity (226)
Opinion (182)
Patents (98)
People (56526)
Phase I (19964)
Phase II (28302)
Phase III (21094)
Pipeline (441)
Postmarket research (2554)
Preclinical (8502)
Radiopharmaceuticals (234)
Rare diseases (206)
Real estate (5935)
Regulatory (21559)
Research institute (2315)
Resumes & cover letters (350)
Southern California (1267)
Startups (3612)
United States (13055)
Vaccines (549)
Weight loss (166)
Date
Last 7 days (922)
Last 30 days (3417)
Last 365 days (35509)
2024 (32196)
2023 (40177)
2022 (51287)
2021 (55836)
2020 (54157)
2019 (46644)
2018 (35124)
2017 (32222)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26499)
2012 (28770)
2011 (29426)
2010 (27525)
Location
Africa (716)
Arizona (190)
Asia (37292)
Australia (6098)
California (3201)
Canada (1255)
China (238)
Colorado (143)
Connecticut (143)
Europe (79921)
Florida (438)
Georgia (112)
Illinois (339)
Indiana (191)
Kansas (97)
Maryland (567)
Massachusetts (2529)
Michigan (153)
Minnesota (268)
New Jersey (920)
New York (927)
North Carolina (690)
Northern California (1416)
Ohio (135)
Pennsylvania (817)
South America (1094)
Southern California (1267)
Texas (438)
Utah (88)
Washington State (352)
687,833 Results for "aadi bioscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Aadi Bioscience to Lay Off 80% of R&D Staff
Aadi Bioscience expects that pipeline adjustments and the workforce reduction will extend its cash runway into at least the second half of 2026.
August 21, 2024
·
1 min read
·
Angela Gabriel
Biotech Beach
Aadi Bioscience to Participate in the Jefferies Healthcare Conference
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on developing and commercializing therapies for cancers with alterations in the mTOR pathway, announced today participation in the Jefferies Healthcare Conference, taking place June 5-6, 2024, in New York.
May 29, 2024
·
1 min read
Business
Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update
Aadi Bioscience, Inc. today announced that it will host a conference call and live webcast on Wednesday, May 8, 2024.
May 1, 2024
·
2 min read
Press Releases
Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update
October 30, 2024
·
1 min read
Press Releases
Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update
November 6, 2024
·
6 min read
Biotech Beach
Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting
Aadi Bioscience, Inc. (NASDAQ: AADI) today announced new nonclinical data demonstrating the significantly higher intratumoral drug concentration, stronger inhibition of mTOR targets and greater antitumor activity of nab-sirolimus compared to intravenous and oral mTOR inhibitors in a xenograft model.
May 23, 2024
·
6 min read
Business
Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update
Aadi Bioscience today announced financial results for the first quarter ended March 31, 2024, and highlighted recent corporate progress.
May 8, 2024
·
8 min read
Biotech Beach
Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update
Aadi Bioscience, Inc. today announced that it will host a conference call and live webcast on Wednesday, March 13, 2024.
March 6, 2024
·
1 min read
Biotech Beach
Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual Meeting
Aadi Bioscience, Inc. (NASDAQ: AADI) today announced it will present new non-clinical data that highlight the combinability of nab-sirolimus and its potential for synergy to enhance anti-cancer effects and overcome resistance.
April 9, 2024
·
5 min read
Biotech Beach
Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conference
Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients with mTOR pathway alterations, announced today its presentation at the TD Cowen 44th Annual Healthcare Conference, taking place March 4-6, 2024, in Boston.
February 26, 2024
·
1 min read
1 of 68,784
Next
